| |
| |
|
| Insider
Information: |
Watanabe Todd Franklin |
| Relationship: |
See Remarks, Director |
| City: |
Westlake Village |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
860,750 |
|
|
Indirect Shares
|
231,140 |
|
|
| Direct
Value |
$6,231,830 |
|
|
|
Indirect Value
|
$1,673,454 |
|
|
| Total
Shares |
1,091,890 |
|
|
| Total
Value |
$7,905,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arcutis Biotherapeutics, Inc. |
ARQT |
See Remarks, Director |
2024-05-02 |
860,750 |
2024-05-02 |
231,140 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-07-06 |
4 |
AS |
$26.58 |
$46,515 |
D/D |
(1,750) |
594,779 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-08-05 |
4 |
OE |
$1.68 |
$1,681 |
D/D |
1,000 |
595,779 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-08-05 |
4 |
AS |
$20.81 |
$20,810 |
D/D |
(1,000) |
594,779 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-09-07 |
4 |
AS |
$21.14 |
$21,137 |
D/D |
(1,000) |
594,779 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-09-07 |
4 |
OE |
$1.68 |
$1,681 |
D/D |
1,000 |
595,779 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-10-01 |
4 |
OE |
$1.68 |
$2,521 |
D/D |
1,500 |
596,279 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-10-01 |
4 |
AS |
$25.01 |
$37,510 |
D/D |
(1,500) |
594,779 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-10-05 |
4 |
OE |
$1.68 |
$4,202 |
D/D |
2,500 |
597,279 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-10-05 |
4 |
AS |
$24.92 |
$62,294 |
D/D |
(2,500) |
594,779 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-11-05 |
4 |
AS |
$21.50 |
$21,502 |
D/D |
(1,000) |
594,779 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-11-05 |
4 |
OE |
$1.68 |
$1,681 |
D/D |
1,000 |
595,779 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-12-08 |
4 |
OE |
$1.68 |
$1,681 |
D/D |
1,000 |
595,779 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-12-08 |
4 |
AS |
$17.00 |
$17,000 |
D/D |
(1,000) |
594,779 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-01-05 |
4 |
AS |
$21.11 |
$21,592 |
D/D |
(1,000) |
594,779 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-01-05 |
4 |
OE |
$1.68 |
$1,681 |
D/D |
1,000 |
595,779 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-02-09 |
4 |
OE |
$1.68 |
$1,681 |
D/D |
1,000 |
595,779 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-02-09 |
4 |
AS |
$17.00 |
$17,000 |
D/D |
(1,000) |
594,779 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-03-01 |
4 |
AS |
$17.75 |
$38,222 |
D/D |
(2,153) |
592,626 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
70,900 |
663,526 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-03-04 |
4 |
AS |
$16.86 |
$41,962 |
D/D |
(2,489) |
661,037 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-03-07 |
4 |
OE |
$1.68 |
$1,176 |
D/D |
700 |
661,667 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-03-07 |
4 |
AS |
$16.44 |
$13,125 |
D/D |
(770) |
660,967 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-03-09 |
4 |
AS |
$17.00 |
$5,100 |
D/D |
(300) |
660,667 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-04-05 |
4 |
AS |
$21.43 |
$21,430 |
D/D |
(1,000) |
659,667 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-05-05 |
4 |
AS |
$21.76 |
$21,760 |
D/D |
(1,000) |
658,667 |
0 |
% |
|
76 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
